Bpifrance

Bpifrance is a financial institution dedicated to supporting companies throughout their development stages, particularly those preparing for stock market listing and seeking credit equity. The organization provides a range of financial solutions, including financing, innovation assistance, and capital investment. By integrating various entities such as OSEO and CDC Entreprises, Bpifrance aims to deliver tailored financial support that addresses the specific needs of businesses. The institution is committed to fostering innovation and helping companies transition toward sustainable growth, ensuring they are well-equipped to face future challenges.

Laurent Arthaud

Managing Director

Marion Aubry

Investment Director

Emmanuel Audouard

Director of Transverse Venture Capital Investments Division

Benoit Barteau Ph.D

Investment Director

Nicolas Berdou

Investment Director, Defense Expert

Clarisse Blandin

Investment Director

Elyssa Maufras du Châtellier

Investment Director

Edouard Combette

Investment Director

Charlotte Corbaz

Deputy Director of the Large Venture Fund and Deputy Managing Director

Nicolas Dardenne

Senior Investment Director, Normandy (Caen Rouen)

Arnaud Despoisse

Director of Occitanie Participations

Philippe Dutheil

Investment Director

Mailys Ferrere

Director of Large Venture Investments

Paul-Francois Fournier

Executive Director, Innovation Department

Pierre Gillet

Investment Director

Vanessa Giraud

Director of Environmental Impact Funds

Gwenael Hamon

Investment Director

Laurent Higueret Ph.D

Senior Investment Director

Louis Janneau

Investment Director and Fund Manager

Magali Joessel

Director of Funds

So-Yeon Koo

Senior Investment Manager

Jérôme Langlade

Investment Director Aquitaine / Limousin / Poitou-Charentes

Eric Lefebvre

Director

Stephane Lefevre-Sauli

Senior Investment Director

Arnaud Legardeur

Investment Director

Chahra Louafi

Senior Investment Director

Serge Mesguich

Director of FIT

Laure Michel

Investment Director

Louis Molis

Investment Director

Jean-Francois Morin

Investment Director

Sébastien Moynot

Director

Adrien Muller

Investment Director

Adrien Néel

Investment Director

Axel Piriou

Director of Investments

Olivier Rameil

Senior Investment Director / VC seed

Vincent Roque

Director

Thibaut Roulon Ph.D

Investment Director

Gilles Schang

Deputy Director

Jean-Marie Fougeray

Senior Investment Director, Brittany

Past deals in Early Venture Stage

Chipiron

Series A in 2025
Chipiron is a developer of advanced portable MRI machines that utilize cutting-edge quantum detectors to generate high-resolution three-dimensional anatomical images. By operating at ultra-low magnetic fields, these machines are designed to be lightweight and cost-effective, significantly reducing the price compared to traditional MRI systems. Chipiron's technology aims to enhance disease detection, diagnosis, and treatment monitoring, particularly for brain-related conditions, thereby assisting healthcare institutions in improving patient outcomes and potentially decreasing fatality rates associated with these ailments.

Versant

Grant in 2025
Tech solution to accelerate biodiversity restoration.

Faume

Series A in 2025
Faume operates a technology and logistics platform that provides a comprehensive white label solution for businesses aiming to enhance their market presence. The company focuses on engaging brands and their customers to foster a circular economy, facilitating sustainable business practices. Faume's platform includes services such as site design, communication, product photography, and customer service, allowing brands to seamlessly integrate operations into their existing frameworks. By enabling clients to effectively manage their secondhand businesses, Faume helps them attract new customers, retain existing ones, and increase long-term revenue for both physical and online stores.

Galam Robotics

Series A in 2025
Galam Robotics specializes in modular robotic solutions aimed at enhancing logistics and storage processes. The company develops innovative robotics technology that significantly increases productivity and efficiency in various trades and urban logistics. By transforming storage capabilities within constrained spaces, Galam Robotics enables clients to optimize their storage capacity while maximizing input and output flows. This focus on modularity allows for tailored solutions that meet diverse operational needs, making it easier for businesses to adapt to changing demands in logistics and storage management.

Mabqi

Grant in 2025
Mabqi, headquartered in Grabels, France, is a biopharmaceutical company specializing in immunotherapy. It operates an antibody discovery platform, enabling the identification and development of innovative, proprietary therapeutic molecules.

The QA Company

Series A in 2025
The QA Company specializes in AI-driven knowledge management solutions. It develops a question-and-answer platform that streamlines access to internal information, supporting decision-making and enhancing productivity across diverse industries such as HR, project management, legal, and technical support. The platform enables businesses to create AI chat assistants for their documents and websites.

Keey Aerogel

Series A in 2025
Keey Aerogel is a specialized manufacturer of silica aerogel, utilizing a closed-loop process that recycles construction waste, carbon dioxide, and ethanol. The company focuses on the valorization of silica-containing materials from construction and demolition activities, aiming to create energy-efficient building solutions and materials for various industrial applications. By producing this innovative nanoporous material, Keey Aerogel provides effective thermal insulation in ambient conditions, contributing to sustainability in construction and refurbishment projects.

Hexana

Grant in 2025
HEXANA is a nuclear energy company specializing in small modular reactors (SMRs). It operates sodium-cooled fast neutron reactors, integrated with high-temperature storage systems, to produce flexible electricity on demand and provide direct process heat. The company's technology aims to reduce the volume of nuclear waste, contributing to a cleaner and more efficient energy industry.

AISPRID

Series A in 2025
AISPRID is a robotic company that manufactures autonomous robots for soft fruit picking.

Coave Therapeutics

Series A in 2025
Coave Therapeutics specializes in developing gene therapies for rare ocular and central nervous system (CNS) diseases. Their primary focus is creating treatments for rare retinal disorders using a recombinant adeno-associated virus vector, which delivers a functional copy of the PDE6B gene directly between photoreceptors and the retinal pigment epithelium to provide effective visual restoration.

NEBULA

Grant in 2024
NEBULA maps 3D macromolecule using dataset-free genAI and physics, enhancing drug target discovery, which forms the basis of all new drugs.

GAiF Ai

Series A in 2024
GAiF Ai is an online community driving Africa's generative AI revolution.

Biomemory

Series A in 2024
Biomemory is a deep-tech company focusing on innovative data storage solutions for large enterprises and institutions. It leverages molecular engineering to create cost-effective, energy-efficient appliances that enable exabyte-scale storage. The company's advanced data storage drives utilize a biobased system that encodes substantial amounts of data on long DNA strands, significantly surpassing the capacity of traditional storage methods such as solid-state drives and magnetic tapes. Biomemory's technology offers remarkable durability, ensuring data stability at ambient temperatures without the need for energetic input or CO2 emissions, making it an environmentally friendly choice. This approach provides researchers and organizations with a long-lasting storage solution, capable of preserving information for thousands of years.

Mirabelle

Grant in 2024
Mirabelle is a technology-driven financial services company focused on addressing the financial needs of retirees. It specializes in offering reverse mortgage loans and life annuities, with a commitment to providing secure and informed decision-making processes. The company's core business involves advising on life annuity financing, ensuring retirees have access to guaranteed monthly income supplements, and assisting with senior housing renovations. Mirabelle's mission is to enable retirees and their families to live comfortably and securely in their homes during their golden years.

Lingua Custodia

Grant in 2024
Lingua Custodia SAS, founded in 2011 and based in Montigny-le-Bretonneux, France, specializes in developing SaaS-based software solutions for the financial sector, focusing on machine translation and Natural Language Processing (NLP). The company offers a range of services, including customized translation software and document-specific solutions, which streamline the translation process for finance professionals. Its platform is designed to handle various document types, such as fund prospectuses and annual reports, while also providing advanced NLP applications like Speech-to-Text automation and data extraction. Lingua Custodia serves a diverse clientele, including financial institutions, language service providers, and asset management firms, enabling them to efficiently manage their translation needs with high-quality, domain-focused machine learning algorithms. The company has gained recognition for its innovative technology and commitment to enhancing translation processes in the finance industry.

Hub2.Io

Series A in 2024
Hub2.Io is a system for digitizing ongoing transactions. Services like cash out, to pay, manage, and others are offered by them. Connecting businesses to their infrastructure will enable them to accept and process payments quickly and safely.

Meiogenix

Series A in 2024
Meiogenix is a biotechnology company focused on developing innovative breeding technologies aimed at harnessing the untapped genetic diversity of various organisms. By modulating homologous recombination frequencies in eukaryotic cells, Meiogenix enhances natural biodiversity and facilitates the creation of new products. This approach is designed to help businesses tackle pressing global food and industrial challenges, ultimately contributing to sustainable solutions in these sectors.

FairCraft

Series A in 2024
FairCraft is a company focused on creating a sustainable alternative to traditional animal leather through innovative synthetic biology and material science techniques. By utilizing cellular culture, tissue engineering, and advanced material science, FairCraft develops lab-grown leather that provides a slaughter-free option for the fashion industry. This approach not only aims to reduce CO2 emissions associated with conventional leather production but also ensures high mechanical strength and durability for consumers. Through its commitment to sustainability and cutting-edge technology, FairCraft is positioned to transform the leather market by offering environmentally friendly solutions.

Interactive Autonomous DYnamic Systems

Grant in 2024
Iadys designs, develops, and delivers robotic and AI innovations aimed at environmental preservation. The company's flagship product, the Jellyfishbot, is a robot that collects floating waste and oil in water bodies and performs underwater measurements. Iadys also offers the Mobile Oil Skimmer, which is used for oil spill response. These products are designed to access and clean hard-to-reach areas, contributing to cleaner and safer aquatic environments.

Fudzs

Grant in 2024
Fudzs specializes in sustainable bioeconomy, focusing on developing eco-friendly cell bioproduction processes using advanced bioreactor technology. By integrating biomaterial engineering with cellular science, the company enables cost-effective mass production of cells, opening new market avenues. Fudjs' primary goal is to revolutionize affordable cultivated meat production and transform cell therapies through scalable, future-oriented solutions.

Beyond Aero

Series A in 2024
Hangarar is an aeronautical services platform based in Brazil that focuses on enhancing general aviation. The company aims to transform the market by providing timely and secure information to pilots, ensuring they have access to organized data whenever needed. By streamlining the booking process through a mobile platform, Hangarar simplifies the logistics of finding and securing aviation services at various destinations, allowing pilots to concentrate on flying.

Beyond Aero

Series A in 2024
Beyond Aero is a pioneering company focused on developing the first electric business aircraft powered by hydrogen propulsion. Founded in December 2020, the firm is redesigning the architecture of a CS23 aircraft to utilize hydrogen-electric propulsion, emphasizing fuel cell technology, hydrogen tank integration, and advanced cooling systems. Based in Toulouse, Paris, and Los Angeles, Beyond Aero has assembled a team of over 50 engineers, with plans to expand its workforce further. The company has successfully raised more than $44 million in funding and has secured $914 million in Letters of Intent for 108 aircraft. Notably, it achieved a significant milestone by completing France's first manned, fully hydrogen-electric flight. Beyond Aero is also actively involved in initiatives aimed at promoting zero-emission aviation, including being a member of the World Economic Forum's First Movers Coalition and the Alliance for Zero Emission Aviation, reflecting its commitment to creating energy-efficient aircraft that minimize environmental impact.

Okomera

Grant in 2024
Okomera is a biotech start-up focused on enhancing access to more effective, precision-based cancer therapies. The company has pioneered the automation and miniaturization of individualized tumor biopsy research, developing advanced medical technologies that leverage microfluidic 3D cellular assays. These innovative technologies enable the prediction of patient-specific responses to cancer treatments by automating relevant biopsy testing. In this process, tumor cells are cultivated within thousands of microfluidic droplets and exposed to numerous conditions simultaneously. This approach allows healthcare providers to expedite the development and delivery of modern cancer therapies, ultimately improving treatment outcomes for patients.

Kriptown

Series A in 2024
Kriptown is a financial platform focused on providing funding solutions for regional startups and small to medium-sized enterprises (SMEs). The company utilizes advanced technology to facilitate equity funding, enabling investors to purchase tokens linked to the value of a startup's shares. By democratizing access to fundraising, Kriptown allows private individuals to invest in promising ventures while offering startups a streamlined and cost-effective method to raise capital. Each funding opportunity on the platform is accompanied by a standardized whitepaper, ensuring that investors have comprehensive information prior to subscription. Kriptown emphasizes customer satisfaction, innovation, and accessibility, creating a vibrant marketplace where digital assets can be stored, utilized, or exchanged.

VELA

Series A in 2024
VELA is an innovative 100% wind-powered maritime transport. It has been working to address the climate emergency by providing a creative, sustainable, and socially responsible maritime transportation solution.

Inbolt

Series A in 2024
Inbolt is a company focused on enhancing industrial operations through advanced vision systems for robots. It has developed a vision-based artificial intelligence that enables real-time decision-making in various environments, allowing for smarter automation of complex tasks. The company's technology includes a tool positioning system that provides real-time quality control for manual operations such as torquing, drilling, and riveting. By implementing these innovations, Inbolt aims to reduce errors in operations and improve overall quality control, thereby streamlining industrial processes and increasing efficiency.

Patrowl

Series A in 2024
Patrowl is a cybersecurity company that specializes in automating vulnerability detection and remediation. Designed by cybersecurity experts, the platform employs artificial intelligence to conduct continuous penetration tests, enabling real-time identification of both known and shadow IT assets and vulnerabilities. Patrowl provides users with a clear visualization of their overall security posture and offers tailored solutions for remediation, which can be easily implemented or communicated to relevant teams. The platform also allows for quick verification of fixes through retesting, ensuring that vulnerabilities have been addressed effectively. By simplifying cybersecurity processes, Patrowl aims to enhance clients' security measures and deter cybercriminals, making effective cybersecurity accessible to a broader audience.

Hepta Medical

Series A in 2024
Hepta Medical is a medical technology company focused on developing innovative treatments for early lung cancer through minimally invasive, nonsurgical methods. The company's flagship product is a microwave ablation platform that employs a specialized catheter equipped with an integrated temperature sensor. This technology allows healthcare professionals to monitor and control the ablation volume in real-time, enhancing the precision of the treatment. By enabling targeted ablation while managing the size of the lesion, Hepta Medical aims to improve patient outcomes and increase the safety and efficiency of cancer therapies.

Enalees

Series A in 2024
Enalees is a biotechnology company focused on developing molecular diagnostic tests specifically for pets, with a particular emphasis on leisure animals such as horses. The company has created a platform that provides DNA tests designed to detect the microbes responsible for infectious diseases. These tests enable veterinarians to quickly identify the pathogens causing an animal's illness, facilitating timely and accurate diagnosis. By supplying veterinary clinics with diagnostic test kits, Enalees aims to enhance the efficiency of infectious disease management in animals, ultimately improving animal health outcomes.

Aura Aero

Grant in 2024
Aura Aero is a manufacturer of aircraft dedicated to advancing air transport decarbonization through the design and production of eco-efficient and low-carbon vehicles. The company focuses on creating innovative aircraft that feature a comprehensive rescue parachute system, anti-crash seats, and anti-crash fuel tanks. With a two-seater configuration and side-by-side taildragger landing gears, Aura Aero aims to enhance the safety and efficiency of aviation. Their commitment to environmentally friendly technology positions them as a key player in the drive towards sustainable air travel.

Yumgo

Series A in 2024
Yumgo is a plant-based egg startup focused on creating alternatives to traditional eggs for baking and cooking. The company develops both white and yellow egg substitutes made from vegetable proteins, specifically designed to be free of allergens. Yumgo aims to facilitate a shift towards sustainable eating by providing products that allow consumers to maintain healthy dietary habits without sacrificing flavor in sweet and savory dishes. Through its innovative offerings, Yumgo addresses the growing demand for plant-based food options.

Ray studios

Series A in 2024
Ray Studios is a Tattoo removal studio that employs hydraulic acoustic wave technology in its "Le Ray Spark" Tattoo removal treatment device.

GenoMines

Grant in 2024
GenoMines is a company focused on sustainable mining through innovative biological methods. It specializes in using plant-based technologies to extract critical metals from soils that are below traditional cut-off grades. By genetically enhancing hyperaccumulator plants, GenoMines leverages nature's ability to absorb metals, thereby not only sustainably mining these resources but also depolluting soils and increasing the availability of agricultural sites. This approach addresses significant environmental and societal challenges associated with conventional mining methods, aiming to support the transition to green energy in a responsible manner.

Continuity

Series A in 2024
Continuity offers a software-as-a-service (SaaS) platform that utilizes artificial intelligence and open data to identify outdated or invalid insurance contracts. The platform operates across four key product lines: Professional Indemnity, Commercial Property, Construction Workers Insurance, and Directors & Officers Liability. By analyzing data consistently and at scale, Continuity provides insurers with a comprehensive view of small and medium-sized enterprises (SMEs), ensuring that each business is adequately covered throughout its lifecycle. This innovative approach helps to enhance the accuracy and reliability of insurance coverage for SMEs.

LAfricaMobile

Series A in 2024
LAfricaMobile is a digital multichannel cloud communication platform based in Dakar, Senegal, founded in 2014. The company specializes in mobile marketing services, enabling enterprises across Africa to strengthen their connections with customers via mobile phones. LAfricaMobile offers customized solutions tailored to the local context, facilitating seamless communication between businesses and their clientele. Its adaptable platform supports multi-operator, multi-channel, and multi-country capabilities, allowing companies to effectively reach diverse audiences while providing end consumers with instant, safe, and secure access to essential information.

Biodol Therapeutics

Grant in 2024
Biodol Therapeutics SAS is a biotechnology company based in Clapiers, France, established in 2015. The company focuses on developing innovative compounds for the treatment of chronic pain, specifically targeting the Receptor Tyrosine Kinase (RTK) FLT3, which plays a critical role in triggering and sustaining chronic neuropathic pain. Biodol Therapeutics' research indicates that inhibiting FLT3 can enhance the effectiveness of opioids, potentially reducing their risk of addiction and contributing to solutions for the opioid crisis. By creating extracellular inhibitors of the FLT3 receptor, the company aims to alleviate pain hypersensitivity, allodynia, and spontaneous pain while preserving normal nervous system function. Through academic partnerships, Biodol Therapeutics continues to advance its understanding of pain mechanisms and develop its proprietary therapeutic approaches.

Eyco

Series A in 2024
Eyco is a manufacturer specializing in the design and production of smart circuits and hardware elements for the digital applications sector. Operating within the European microelectronics industry, the company focuses on creating innovative industrial machinery that minimizes environmental impact. By ensuring efficient mass production tailored to client specifications, Eyco enables secure digital applications while promoting sustainability in technology. Its commitment to advancing the high-tech ecosystem of electronics positions Eyco as a key player in the development of environmentally responsible solutions in the digital landscape.

HEPHAISTOS-Pharma

Grant in 2024
Hephaistos Pharma is a biotechnology firm dedicated to advancing oncology treatments through innovative immunotherapy solutions. The company focuses on developing next-generation therapies that utilize active and non-specific immuno-stimulants, which enhance the efficacy of existing antibodies and transform cold tumors into hot targets for the immune system. By addressing unmet medical needs, Hephaistos Pharma aims to provide effective treatment options for patients with incurable cancers. Their platform is designed to stimulate immune responses, thereby improving the overall efficiency of immunotherapy. The firm also offers an online inquiry form on its website for further engagement.

Magnetfab

Grant in 2024
Magnetfab pioneers the mass-production of integrated micromagnets, driving advanced miniaturization for next-generation consumer electronics, robotics, quantum computing, and beyond.

Touch Sensity

Grant in 2024
Touch Sensity is an information technology company focused on the development of sensitivity technology that enhances the interaction between objects and their environments. It specializes in Internet of Things (IoT) applications and advanced sensor technology, creating solutions that are adaptable to various sizes, shapes, and surface topologies. The company's innovative approach is sensorless and non-invasive, allowing for the comprehensive capture of data related to pressure, extension, and deformation across complete surfaces. This capability enables clients to gather and analyze detailed information about physical interactions, thereby enhancing the functionality and responsiveness of their products and systems.

Ascendance

Funding Round in 2024
Founded in 2018 by four ex-Airbus engineers: Jean-Christophe Lambert, Thibault Baldivia, Clément Dinel and Benoît Ferran, Ascendance is an industrial start-up with a mission to decarbonise aviation. Based in the heart of Toulouse, the European capital of aviation, it has developed and markets two products: an innovative hybrid-electric propulsion system ‘Sterna’, and a hybrid-electic vertical take-off and landing (VTOL) aircraft powered by Sterna technology, ‘Atea’.

Tribun Health

Grant in 2024
Tribun Health is a company focused on transforming cancer detection through innovative diagnostic imaging software. Its solutions enable diagnostic laboratories and the pharmaceutical and biotech sectors to effectively manage, analyze, and share cellular images. By offering digital microscopy-like analysis along with macroscopic imaging capabilities, Tribun Health enhances the accuracy of diagnostics and scientific evaluations related to patient cells and tissues. The company's technology aims to streamline the workflow in laboratories, facilitating better collaboration and data sharing among healthcare professionals.

SeaBeLife

Grant in 2024
SeaBeLife Biotech SAS is a biotechnology company based in Roscoff, France, established in 2019. The company focuses on developing innovative drug candidates aimed at treating acute pathologies, particularly acute liver and renal failure. SeaBeLife's products are derived from a family of patented molecules designed to block regulated necrosis, a type of regulated cell death. By targeting two synergistic pathways involved in various acute and chronic diseases, SeaBeLife aims to establish a new standard of care for patients with significant unmet medical needs. Through its research and development efforts, the company seeks to enhance patient outcomes and reduce complications associated with serious health conditions.

Chipiron

Grant in 2024
Chipiron is a developer of advanced portable MRI machines that utilize cutting-edge quantum detectors to generate high-resolution three-dimensional anatomical images. By operating at ultra-low magnetic fields, these machines are designed to be lightweight and cost-effective, significantly reducing the price compared to traditional MRI systems. Chipiron's technology aims to enhance disease detection, diagnosis, and treatment monitoring, particularly for brain-related conditions, thereby assisting healthcare institutions in improving patient outcomes and potentially decreasing fatality rates associated with these ailments.

Surge

Grant in 2024
Surge is a biotechnology company dedicated to enhancing surgical outcomes for patients. It has developed an advanced immunological model known as Surge2surgery, which predicts postoperative infections. This innovative platform integrates a single-cell analysis of the immune system conducted prior to surgery with clinical data, utilizing a proprietary machine-learning algorithm. By examining millions of immune cells from a small blood sample, Surge's technology simulates surgical trauma in a controlled environment, allowing for improved predictions and potentially better patient care.

Alice & Bob

Grant in 2024
Alice & Bob is a Paris-based company founded in 2020 that specializes in the manufacture of universal, error-free quantum computers. The company’s innovative technology features self-correcting superconducting quantum bits, which provide fault-tolerant capabilities and allow for the execution of any quantum algorithm. By offering these advanced computing solutions, Alice & Bob aims to assist industries and researchers in tackling complex problems that require quantum computing power.

Sequans Communications

Grant in 2024
Sequans Communications S.A. is a designer and supplier of cellular semiconductor solutions, specializing in 4G and 5G chips and modules tailored for massive, broadband, and critical Internet of Things (IoT) markets. Established in 2003 and headquartered in Paris, France, the company offers a diverse product portfolio that includes its Monarch LTE-M/NB-IoT and Calliope Cat 1 chip platforms for 5G/4G massive IoT applications, known for their low power consumption and integrated functionalities. For broadband and critical IoT applications, Sequans provides the Cassiopeia Cat 4/Cat 6 4G and high-end Taurus 5G chip platforms, which are optimized for various sectors including residential, enterprise, and industrial uses. The company serves a global market with additional offices in the United States, United Kingdom, Israel, Hong Kong, Singapore, Taiwan, South Korea, and China.

ABIONYX Pharma

Grant in 2024
ABIONYX Pharma SA is a French biopharmaceutical company established in 2005, currently based in Labege. It specializes in the discovery and development of therapies targeting high-density lipoprotein (HDL) for treating cardiovascular and metabolic diseases. The company's primary focus is on developing HDL mimetics to rapidly regress atherosclerotic plaque in high-risk patients. Its lead product candidate, CER-001, is a Phase II clinical trial asset designed to mimic the properties of pre-beta HDL for treating post-acute coronary syndrome patients and familial primary hypoalphalipoproteinemia patients. Additionally, ABIONYX Pharma has another drug candidate, CER-209, in Phase I trials for metabolic diseases and liver-related conditions such as atherosclerosis and non-alcoholic steato-hepatitis.

Sunver

Grant in 2024
Sunver is a start-up offering the first fully plug & play B2B SaaS solution for tourism establishments and restaurants, enabling them to create and configure a Guest App in just a few minutes.

Hawkcell

Series A in 2024
HawkCell is a medical research company specializing in advanced magnetic resonance imaging (MRI) solutions for veterinary clinics and preclinical research laboratories. By utilizing a non-ionizing three-dimensional (3D) imaging approach, HawkCell employs specialized MRI sensors designed to accommodate various animal morphologies. The company enhances its services with artificial intelligence algorithms, transforming traditional human MRI technology into dedicated imaging resources tailored for animal diagnostics and scientific exploration. This innovative approach provides veterinary clinics and research labs with precise and insightful tools for improving animal healthcare and advancing research initiatives.

UniFox

Grant in 2024
UniFox is an AI-powered ecosystem focused on sustainable investment, integrating green energy and eco-responsible technologies into its offerings for both individual and institutional investors. The company operates through four divisions: B2C, B2B, Capital Ventures, and Green DeFi. Its flagship product, VulpesAI, is a multi-modal AI engine that analyzes market data, sentiment, and environmental, social, and governance (ESG) factors to create optimized investment strategies. VulpesAI is designed to be environmentally friendly, utilizing renewable energy sources and low-frequency micro-servers to minimize its carbon footprint. The B2C segment provides AI-driven portfolio management, enabling users to access comprehensive market insights and tailor investment strategies based on AI-generated signals. In the B2B sector, UniFox delivers institutional solutions through REST API access to advanced data and metrics for large-scale investments and green projects. Its Green DeFi division finances sustainable technology initiatives, utilizing decentralized finance methods, eco-taxed products, and tokens to support environmentally friendly ventures. UniFox's mission is to democratize investment, making it more accessible and aligned with ecological values while addressing common trading challenges faced by novice investors.

Groover

Series A in 2024
Groover is an innovative platform designed specifically for independent artists, focusing on music promotion and discovery. It has cultivated a community of 200,000 artists across more than 186 countries. The platform allows musicians to directly submit their music to media outlets, radio stations, playlists, and record labels, ensuring they receive valuable feedback from a vetted network of 3,000 music curators and professionals. With over two million feedback interactions on tracks, Groover provides artists with the opportunity to obtain honest insights and tangible sharing proposals, facilitating their growth and visibility in the competitive music industry.

Agrilife Studio

Series A in 2024
Agrilife Studio is a startup studio dedicated to advancing agriculture and environmental practices. It operates as an agri-tech incubator, providing farmers with a comprehensive suite of tools and resources designed to enhance the efficiency and productivity of their operations. The company offers data analytics, precision agriculture tools, and improved market access, enabling farmers to make informed decisions regarding their crops and livestock. By facilitating better connections with buyers, Agrilife Studio aims to support the agricultural community in achieving greater success and sustainability.

Greenerwave

Series A in 2024
Greenerwave is a company focused on improving wireless indoor connectivity through innovative technology. It develops electronically reconfigurable surfaces that function as electromagnetic mirrors, effectively addressing connectivity and mobility challenges. This technology enables the creation of cost-effective and low-energy beamforming antennas and radars, aiming to enhance the overall wireless experience for users. By prioritizing reliable indoor connections, Greenerwave seeks to transform the way customers interact with wireless networks.

Panopli

Series A in 2024
Panopli is a customization service based in Saint-Ouen, France, established in 2017. The company operates an online marketplace that specializes in personalized gifts, including artistic clothing, decorative items, and various gift solutions such as art pieces, t-shirts, sweaters, shorts, and posters. Panopli's platform simplifies the gifting process by allowing users to browse and select items, which are then directly shipped to the recipient. This service aims to make gift-giving more accessible and convenient, ensuring that customers can find and send artistic goods without the hassle of managing orders and deliveries themselves.

AQEMIA

Series A in 2024
AQEMIA is a pharmaceutical technology company specializing in drug discovery. It employs a proprietary platform that integrates quantum-inspired physics with machine learning algorithms to accelerate and enhance the identification of new drug candidates tailored to specific therapeutic targets. This innovative approach enables AQEMIA to generate a robust pipeline of novel drug leads, aiming to improve efficiency and accuracy in predicting the affinity between drug candidates and their intended targets.

Aldoria

Series A in 2024
Aldoria specializes in space situational awareness, focusing on the collection, processing, and utilization of data to protect vital assets in orbit. The company addresses the growing challenges of space sustainability caused by increasing space debris and traffic. Aldoria's services encompass the detection, tracking, and cataloging of artificial satellites and space debris, as well as assessing collision risks. By providing a new-generation platform for space situational awareness and comprehensive sustainability reports, Aldoria empowers operators and space organizations to navigate safely and effectively, helping them avoid potential hazards and make informed decisions regarding orbital maneuvers.

Temo

Series A in 2024
Temo is a manufacturer of portable electric motors designed for small watercraft, including dinghies, sailing boats, and rowboats. The company focuses on creating lightweight and easy-to-install outboard electric propulsion systems that enhance the user experience on the water. By providing innovative and accessible solutions, Temo aims to improve the functionality and enjoyment of various types of small craft.

I.Ceram

Grant in 2024
I.Ceram SA is a France-based company that specializes in the design, manufacture, and marketing of alumina bio-ceramic implants for various joints of the human body. Founded in 2005 and headquartered in Limoges, I.Ceram offers a range of implants for the ankle, knee, hip, spine, shoulder, wrist, skull, tibia, and foot, as well as osteosynthesis products. The company operates both domestically and internationally, emphasizing innovation and high-quality materials in its product offerings. I.Ceram is a subsidiary of Investissement Développement.

Neocem

Venture Round in 2024
Neocem is a manufacturer that specializes in producing low-carbon cements for the construction industry. The company focuses on creating innovative binding materials derived from calcined flash clays, which are designed to reduce the carbon footprint associated with traditional cement production. Neocem utilizes a novel procedure that allows for the incorporation of raw materials sourced from recovery sectors, thereby promoting sustainability in building practices. Through its commitment to environmentally friendly solutions, Neocem aims to contribute to a greener future in construction.

Novacium

Grant in 2023
Novacium operates as an innovative start-up that specializes in the next generation material development.

Okomera

Grant in 2023
Okomera is a biotech start-up focused on enhancing access to more effective, precision-based cancer therapies. The company has pioneered the automation and miniaturization of individualized tumor biopsy research, developing advanced medical technologies that leverage microfluidic 3D cellular assays. These innovative technologies enable the prediction of patient-specific responses to cancer treatments by automating relevant biopsy testing. In this process, tumor cells are cultivated within thousands of microfluidic droplets and exposed to numerous conditions simultaneously. This approach allows healthcare providers to expedite the development and delivery of modern cancer therapies, ultimately improving treatment outcomes for patients.

Huvy

Grant in 2023
Huvy is a company that utilizes artificial intelligence to enhance dermatological treatment pathways and provide essential medical information in real-time. It has developed a skin cancer screening application aimed at identifying cancer risks. This application facilitates dermatological screenings, particularly benefiting populations in areas with limited access to medical services. By offering initial diagnostic orientation, Huvy's technology enables patients to receive timely care if there is a suspicion of skin cancer, thus improving early detection and treatment outcomes.

EYEGAUGE

Grant in 2023
EyeGauge is a Paris-based deep tech startup focused on the maritime industry. It aims to accelerate decarbonization by automating data collection from ships' systems, replacing manual methods used on 85% of the global fleet. EyeGauge's innovative solution captures consistent, comprehensive data contactlessly and cost-effectively, creating a digital model of vessel equipment for analysis and optimization of operations to reduce greenhouse gas emissions. This enables clients to enhance efficiency, comply with regulations, and gain actionable insights across various services like fuel consumption monitoring, emission reduction tracking, and fleet performance assessment.

Prove & Run

Series A in 2023
Prove & Run has been created with the idea that large scale deployment of connected objects will become a target for remote cyber-attacks and that the technologies in use in the mobile industry were insufficient to answer to the challenge. When designing connected objects, security engineers can in effect rely on three pillars: (1) Secure elements or hardware coprocessors; (2) Trusted Execution Environment (TEE) or secure OSs; (3) Hardware - or software-based hypervisors. In order to resist to sophisticated remote attacks, the last two need to be formally proven so as to be as close as possible to zero-bugs. This is what we have done at Prove & Run with ProvenCore, a formally proven secure OS and ProvenVisor a next generation secure hypervisor. In most cases using of single instance of ProvenCore on a given connected object will be sufficient to protect against hackers with multi-million dollar budgets.

Astraveus

Grant in 2023
Astraveus is a pioneering company specializing in the manufacture of Cell & Gene Therapies (CGTs). It operates the Lakhesysâ„¢ platform, an innovative end-to-end solution that optimizes CGT production using single-use microfluidic bioprocessors. This approach reduces infrastructure requirements, lowers costs, and mitigates logistical challenges, aiming to enhance patient access to life-changing therapies while minimizing environmental impact.

Poppins

Venture Round in 2023
Poppins is a developer of digital therapeutic technology aimed at enhancing cognitive function in children with learning disorders. The company creates interactive musical games that integrate neurologic music therapy methods to address conditions such as dyslexia, dysphasia, and dyspraxia. These games focus on improving essential skills like concentration, motor skills, and memory through engaging activities that can be performed at home. By leveraging data science and advanced technologies, Poppins interprets learning, language, and motor performance to generate a cognitive score, facilitating personalized treatment plans. The company's mission is to provide accessible digital solutions for children facing learning challenges, ultimately aiming to improve their reading abilities and memory retention while supporting speech therapy.

Injectpower

Grant in 2023
Injectpower specializes in developing energy storage technologies and micro-batteries tailored for medical implants. Their core product is a small, solid-state battery that powers implantable devices, enabling them to function as sensors or actuators for extended periods without the need for recharging. With over 16 years of research and 40 patents, Injectpower's batteries are manufactured using a proven semiconductor supply chain, ensuring high reliability. The company's innovative solutions include batteries for devices that monitor intraocular pressure in glaucoma patients and intracranial pressure and fluid flow, allowing physicians to remotely monitor and diagnose conditions more effectively.

Hughy

Grant in 2023
F&B advertising webapp

Albert

Venture Round in 2023
Albert is a software company that provides a SaaS platform. The company was founded in 2018 and is based in Paris, France.

Spark Cleantech

Grant in 2023
Spark Cleantech is a pioneering company developing a plasma technology to convert greenhouse gases into hydrogen fuel. Their proprietary process, called plasmolysis, uses cold pulsed plasma discharges to convert methane or carbon dioxide and methane mixtures into valuable products such as hydrogen, solid carbon, and carbon monoxide. This technology enables the production of competitive, on-site hydrogen, serving as a direct substitute for fossil fuels in decarbonizing industrial heat and powering the transport industry with carbon-neutral hydrogen fuel.

Mecaware

Series A in 2023
Mecaware is a company focused on enhancing strategic autonomy through resource circularity and the intelligent management of material cycles. It specializes in battery recycling technology that recovers critical metals and rare earth elements, thereby promoting a sustainable supply chain for the battery industry. By providing innovative and eco-efficient industrial products and services, Mecaware facilitates the recycling of critical metals from end-of-life batteries and production scraps. This approach not only helps clients secure their supply of essential metals but also significantly reduces environmental impact, aligning with global sustainability goals.

Global Bioenergies

Grant in 2023
Global Bioenergies SA specializes in developing a biological process that converts renewable resources into isobutene, a crucial petrochemical building block used in fuels, plastics, organic glass, and elastomers. The company, based in Evry, France, is notable for being one of the few globally and the only one in Europe focusing on this innovative fermentation technology. It operates an industrial pilot plant and is nearing the completion of a demonstration plant in Germany, alongside preparing for its first full-scale production facility in collaboration with Cristal Union, known as IBN-One. In addition to isobutene, Global Bioenergies has expanded its capabilities to include the production of propylene and butadiene, both vital components in the petrochemical sector. The company was founded in 2008 and continues to enhance the efficiency of its processes while offering engineering services related to gas fermentation.

Niryo

Series A in 2023
Niryo is a manufacturer of educational robots designed to facilitate prototype industrial case studies. The company specializes in open-source six-axis collaborative robots that serve as tools for learning robotics and computer programming. By providing these resources, Niryo aims to support educational institutions in delivering higher education and professional training, thereby enhancing the skills of students and professionals in the field of robotics.

Circul'Egg

Grant in 2023
Circul'Egg is a Paris-based company that specializes in recycling eggshells to create two primary products: calcium carbonate powder and shell membrane powder. By transforming waste from the egg industry, Circul'Egg contributes to the circular economy, promoting sustainable practices in various sectors. Its products cater to the animal feed market, including pet food and feed for farm animals, as well as the nutraceutical and cosmetic industries. The company focuses on providing natural, biobased, and eco-designed solutions that are rich in minerals and beneficial biomolecules, addressing the needs of manufacturers seeking sustainable and nutritious ingredients.

Umiami

Series A in 2023
Umiami is a French food-tech startup founded in 2020 and based in Paris, specializing in plant-based food technology aimed at reducing meat consumption. The company develops innovative plant-based whole-cuts that utilize plant proteins to create alternatives that closely mimic the taste, texture, and aroma of traditional meat products. Through its technological advancements, Umiami seeks to provide consumers with sustainable and appealing food options that align with growing dietary preferences towards plant-based diets.

Remixt

Grant in 2023
Remixt is a leading Diversity, Equity and Inclusion tech platform dedicated to preventing key HR risks caused by harassment and discrimination. The company is headquartered in Paris, France, with employees in Paris, San Francisco, Toulouse and Annecy. Remixt’s clients include global corporations Heineken, Société Générale, Accenture, Groupe BPCE-Natixis and Hexagon. For more information: http://www.remixt.co

Eramet

Grant in 2023
ERAMET is a world leader in alloy metals, including manganese and nickel, and high-end metallurgy. ERAMET also develops activities with high growth potential, such as mineralized sands (titanium dioxide and zircon), lithium and recycling. The Group employs approximately 13,000 people in 20 countries.

Toopi Organics

Grant in 2023
Toopi Organics is a biotechnology company based in Langon, France, that specializes in the collection and upcycling of human urine to create biostimulants for agriculture. Established in 2019, the company develops innovative microbiological and agricultural technologies that transform human urine into effective alternatives to traditional chemical fertilizers. Its products, Arbop and Vitip, are designed to enhance plant growth by utilizing recycled nutrients and microorganisms, providing the agricultural community with sustainable and economical options for improving crop yields. Through its processes, Toopi Organics aims to contribute to environmental sustainability by depolluting and recycling waste materials for agricultural use.

Teale

Series A in 2023
Teale is a prominent digital mental health platform that integrates psychology and technology to facilitate mental health care for individuals and organizations. The company offers personalized and engaging digital healthcare solutions, emphasizing the importance of subconscious well-being. Teale's approach includes individual support and collective workshops tailored to the specific needs of users, thereby enhancing the effectiveness of mental health initiatives. Through its curated network of mental health experts, Teale enables employees to assess their mental health status and access customized digital programs designed to promote their psychological resilience.

Dattak

Series A in 2023
Dattak is a provider of cyber insurance solutions that leverages advanced cybersecurity technologies to enhance risk management for businesses. The company focuses on facilitating insurance brokers in delivering effective resolutions to their clients, particularly targeting small and medium-sized enterprises as well as veterinary specialists and emergency services. By utilizing innovative cybersecurity tools, Dattak assesses the cybersecurity posture of organizations without the need for complicated questionnaires. This approach not only streamlines the insurance process but also equips policyholders with essential tools to prevent and defend against cyberattacks, ultimately helping to reduce overall risk and enhance security in an increasingly digital landscape.

Phagos

Grant in 2023
Phagos is a biotechnology company focused on developing personalized bacteriophage solutions as a sustainable alternative to traditional antibiotics. The company operates a research platform that aims to create customizable drugs specifically designed to replace antibiotics in animal farming. By utilizing bacteriophages, which are natural predators of bacteria, Phagos seeks to provide an effective means of combating incurable and deadly infectious diseases. This innovative approach positions the company as a significant player in the field of alternative therapies, addressing the growing concerns surrounding antibiotic resistance and the need for safer, more sustainable health solutions.

Mob-Energy

Series A in 2023
Mob-Energy is a privately held company founded in 2018 and headquartered in Villeurbanne, Auvergne-Rhône-Alpes. It specializes in the development of innovative charging solutions for electric vehicles. The company designs autonomous charging robots that utilize second-life batteries installed at car parks. These robots can store energy and autonomously move to vehicles that require charging, allowing for a convenient and efficient refueling process. By optimizing existing infrastructure, Mob-Energy aims to enhance the charging experience for electric vehicle owners.

Aviwell

Grant in 2023
Aviwell is a company focused on enhancing animal health and growth through the development of natural and sustainable solutions. Utilizing a microbiota-based platform powered by artificial intelligence and machine learning, Aviwell operates at the intersection of digital and life sciences. The company aims to provide insights that improve animal health and performance while addressing the agri-food industry's challenges in sustainably feeding a growing global population. By prioritizing health and sustainability, Aviwell seeks to offer effective solutions at a reduced cost, ultimately contributing to better nourishment for the planet.

SFE PROCESS

Series A in 2023
SFE Process specializes in the design and manufacture of laboratory equipment, particularly focusing on extraction machines that utilize supercritical fluids. The company develops innovative and modular pressure equipment, providing tailored laboratory systems that cater to a variety of applications. By offering flexible and multipurpose extraction systems, SFE Process enables its clients to efficiently achieve their objectives in diverse research and industrial settings.

Santexpat.fr

Series A in 2023
Santexpat is a health insurance platform designed for French expatriates, offering services in over 200 countries. Founded in 2020 and based in Paris, the company enables users to compare more than 100 health insurance solutions and subscribe directly to policies online, ensuring transparency in pricing by displaying public rates without hidden costs. Additionally, Santexpat provides access to teleconsultations with French-speaking doctors available 24/7, facilitating immediate healthcare support for expatriates.

Cleyrop

Series A in 2023
Cleyrop is a company that specializes in providing a secure data hub designed to simplify and enhance data access for its clients. With a user-friendly portal, Cleyrop offers a scalable application suite that allows users to ingest, store, process, exploit, and visualize data efficiently. The platform includes features such as collaborative workspaces, management of access rights and security, and orchestration of data pipelines. Additionally, it facilitates the viewing and sharing of data insights while enabling effective governance and cataloging of data assets. Cleyrop aims to create an industrial environment that ensures secure and effective management of data, allowing clients to supervise and monitor their data processes seamlessly.

Santé Académie

Series A in 2023
Santé Académie is an innovative online training platform dedicated to enhancing the skills of healthcare professionals. Recognizing the evolving roles of caregivers and the rapid pace of medical knowledge advancement, the company offers high-quality educational videos accessible via web or mobile. Each course is structured into brief episodes lasting 5 to 15 minutes, catering to the busy schedules of doctors, nurses, pharmacists, and care assistants. The curriculum covers essential clinical and regulatory subjects relevant to daily practice, ensuring that participants receive up-to-date information. The courses are certified by the ANDPC and produced by leading experts from esteemed institutions. With a focus on continuous education and engagement, Santé Académie aims to improve patient care throughout the healthcare continuum, a mission supported by over 20,000 professionals and health institutions, including notable organizations such as GHU Paris psychiatrie & neurosciences and Service de Santé des Armées.

Deemea

Grant in 2023
Deemea is a developer of a digital medical assistance platform that focuses on enhancing clinical research and the analysis of real-world data. The company utilizes artificial intelligence to streamline various processes, including identifying appropriate databases, expediting contractual and regulatory tasks, and simplifying external model validation. Deemea's platform aims to optimize responses to both internal and external inquiries while valorizing real-world data and clinical studies. By integrating these capabilities, Deemea helps clients accelerate the development and deployment of innovative projects, ensuring efficiency and reliability in the management of imaging data within the clinical research landscape.

EyeLights

Series A in 2023
EyeLights is a developer of innovative motorcycle accessories focused on enhancing rider safety and experience through advanced technology. The company offers a head-up display GPS that projects crucial navigational and safety information directly into the rider's field of vision, allowing them to maintain focus on the road. This universal accessory alerts motorcyclists to potential hazards, such as sharp bends, traffic signals, and speed limits. Designed for easy installation in under five minutes, EyeLights is compatible with various helmet types, including full-face, convertible, and jet helmets. Its compact optical technology enables visibility of GPS data from over two meters away and features audio functionality for extended use of more than eight hours. The device is built to withstand adverse weather conditions, including rain and fog, while remaining lightweight at less than 100 grams. Overall, EyeLights aims to significantly enhance the safety and enjoyment of motorcycle riding.

Pricemoov

Series A in 2023
Pricemoov is a Paris-based company founded in 2016 that specializes in advanced price management and optimization solutions. Its online platform leverages data science and automation to analyze sales history and current bookings, providing insights into customer demand. By integrating seamlessly with existing information systems, Pricemoov collects and analyzes business data to forecast demand and determine optimal pricing strategies. The platform caters to both B2B and B2C businesses, helping them enhance their digital commerce operations and maximize revenue potential through intelligent pricing. With a focus on user experience, Pricemoov empowers sales teams to adapt to market dynamics effectively.

Kiro

Series A in 2023
Operator of a digital medicine company intended to provide insights on laboratory test results that are understandable to patients. The company fosters the interactions between laboratories, health professionals and patients and goes beyond results in patient care through the use of new technologies and artificial intelligence, enabling medical professionals to easily interpret and diagnose in a personalized and effective way.

XXII

Series A in 2023
XXII is a technology company that specializes in video stream analysis through its SaaS platform, XXIICORE. With a team of over 50 employees, the company focuses on designing, developing, and marketing solutions that enable clients to deploy and configure algorithms for effective video analysis. The platform is utilized across various sectors and by local authorities, allowing organizations to measure the benefits of video analysis in real-time. By facilitating the creation of new tools and applications for their algorithms, XXII helps clients enhance operational performance and optimize their use of video data.

GenoMines

Grant in 2023
GenoMines is a company focused on sustainable mining through innovative biological methods. It specializes in using plant-based technologies to extract critical metals from soils that are below traditional cut-off grades. By genetically enhancing hyperaccumulator plants, GenoMines leverages nature's ability to absorb metals, thereby not only sustainably mining these resources but also depolluting soils and increasing the availability of agricultural sites. This approach addresses significant environmental and societal challenges associated with conventional mining methods, aiming to support the transition to green energy in a responsible manner.

Kovalee

Series A in 2023
Kovalee is a mobile app publisher that supports app creators by providing a comprehensive application publishing platform. The company partners with app owners to elevate their apps in the marketplace, offering services such as product enhancement, user acquisition, monetization, and app store optimization. Kovalee's platform features modular design and application testing, enabling developers to focus on content and code while leveraging data-driven strategies. Additionally, the company employs artificial intelligence to predict customer behavior, helping developers optimize their apps for better performance and profitability.

AlgoTherapeutix

Grant in 2023
AlgoTherapeutix is a biotechnology company focused on developing innovative topical treatments for patients suffering from difficult-to-treat conditions, particularly complex pain syndromes. The company targets damaged nerve fibers in the skin to provide localized pain relief while minimizing the systemic side effects often associated with oral medications. AlgoTherapeutix is actively advancing its lead product, ATX01, which has received FDA approval to enter Phase 2 clinical trials for chemotherapy-induced peripheral neuropathy, a painful condition that lacks proven therapeutic options. Additionally, the company is exploring the potential of its treatments for erythromelalgia, a rare and debilitating disorder characterized by severe pain and inflammation. By tailoring therapies to the specific needs of patients, AlgoTherapeutix aims to improve treatment outcomes for individuals facing these challenging health issues.

Pili

Series A in 2023
PILI Inc. is a biotechnology company based in Paris, France, that specializes in the research and manufacturing of bio-fabricated colors using microorganisms. Founded in 2012, the company focuses on developing enzymes and fermentation biotechnologies that transform sugar into renewable and durable dyes and pigments. By offering a sustainable alternative to traditional toxic and non-recyclable inks, PILI aims to replace petrochemical and vegetable-based colorants with organic dyes produced at an industrial scale. The company's innovative approach not only promotes sustainable development but also enables businesses to reduce costs while utilizing environmentally friendly materials.

Oneleaf

Grant in 2023
Oneleaf is a startup dedicated to making hypnosis more accessible through its innovative app, which assists users in engaging with self-hypnosis techniques. The platform offers a variety of guided programs aimed at addressing wellness issues such as depression, anxiety, smoking cessation, and weight loss. By leveraging expert guidance in a digital format, Oneleaf enables individuals to tackle harmful habits and enhance their overall well-being. The company aims to empower a billion people to realize their potential through self-hypnosis, promoting personal growth and healthier lifestyles.

NFL Biosciences

Grant in 2023
NFL Biosciences is a biotechnology company focused on developing solutions for tobacco addiction. The company specializes in research and development of medicines that utilize both botanical and pharmaceutical agents to aid individuals attempting to quit smoking. Its primary product, NFL-101, is a clinically developed botanical drug designed specifically to target smoking addiction. This innovative treatment contains minimal amounts of nicotine and is formulated from well-characterized natural tobacco leaf proteins, offering a unique approach to support smokers in overcoming their addiction.

Miraxess

Venture Round in 2023
Miraxess is a technology company that specializes in transforming smartphones into functional laptops through its innovative product, the Mirabook. This device acts as a laptop extension, allowing users to connect their smartphones and harness the full capabilities of their mobile devices. As smartphones increasingly serve as the primary tools for personal and professional tasks, Miraxess provides a solution that enhances productivity and comfort for both work and entertainment. By enabling mobile convergence, the company addresses the evolving needs of consumers who seek to maximize the utility of their smartphones in a laptop format.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.